文献
J-GLOBAL ID:201702276531525955
整理番号:17A1549657
ApatinibはEGFR-TKI抵抗性肺非小細胞癌におけるEGFR-TKIの抗腫瘍活性を増強する【Powered by NICT】
Apatinib enhances antitumour activity of EGFR-TKIs in non-small cell lung cancer with EGFR-TKI resistance
著者 (5件):
Li Fang
(Department of Radiation Medicine, School of Basic Medical Science, Peking University, Beijing 100191, China)
,
Zhu Tengjiao
(Orthopedic Department, Peking University International Hospital, Beijing 102206, China)
,
Cao Baoshan
(Department of Tumor Chemotherapy and Radiation Sickness, Peking University Third Hospital, Beijing 100191, China)
,
Wang Jiadong
(Department of Radiation Medicine, School of Basic Medical Science, Peking University, Beijing 100191, China)
,
Liang Li
(Department of Tumor Chemotherapy and Radiation Sickness, Peking University Third Hospital, Beijing 100191, China)
資料名:
European Journal of Cancer
(European Journal of Cancer)
巻:
84
ページ:
184-192
発行年:
2017年
JST資料番号:
A0802C
ISSN:
0959-8049
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)